Cardiovascular Disease in Women

Primary Care - Clinics in Office Practice

Volumn 36, Issue 1, 2009, Pages 73-102

  Weiss, Alan M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular disease; Diabetes; Hypercholesterolemia; Hypertension; Risk; Women

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; CHOLESTEROL; CLOFIBRATE; CLOPIDOGREL; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FIBRINOLYTIC AGENT; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; PROGESTERONE; SIMVASTATIN; WARFARIN;

ABDOMINAL OBESITY; ALCOHOL CONSUMPTION; AWARENESS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; DYSPEPSIA; FLUSHING; FOOD INTAKE; GALLSTONE; GASTROINTESTINAL SYMPTOM; GOUT; HEART INFARCTION; HORMONE SUBSTITUTION; HOSPITAL PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; LIFESTYLE MODIFICATION; LIVER ENZYME BLOOD LEVEL; LIVER TOXICITY; MORBIDITY; MORTALITY; MYOPATHY; OUTPATIENT CARE; PATIENT ASSESSMENT; PATIENT EDUCATION; PHYSICAL ACTIVITY; PHYSICIAN; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SECONDARY PREVENTION; SEX DIFFERENCE; SIDE EFFECT; SITTING; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; UPPER GASTROINTESTINAL DISTRESS; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; DIABETES COMPLICATIONS; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING; UNITED STATES; WOMEN'S HEALTH;

EID: 60649118638     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.10.012     Document Type: Review

References (104)

1. American Heart Association. Heart disease and stroke statistics-2003, update. Available at: http://www.americanheart.org/downloadable/heart. Accessed December 1, 2008.
2. Rogers CC. Changes in the social and economic status of women by metro-nonmetro residence. Available at: http://www.ers.usda.gov/publications/aib732/AIB732a.PDF. Accessed December 1, 2008.
3. Wenger N.K., Speroff L., and Packard B. Cardiovascular health and disease in women. N Engl J Med 329 (1993) 247-256
4. CDC. Preventing heart disease and strokes. Available at:. http://www.cdc.gov/nccdphp/publications/factsheets/Prevention/dhdsp.htm Accessed December 1, 2008
5. Mosca L., Jones W.K., King K.B., et al. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med 9 (2000) 506-515
6. Mosca L., Ferris A., and Fabunmi R. Tracking women's awareness of heart disease. Circulation 109 (2004) 573-579
7. Jackson S.A., and Burke G.L. Heart disease prevention in US women: there is more work to be done. Arch Fam Med 9 6 (2000) 516-517
8. Kaplan G.A., Salonen J.T., Cohen R.D., et al. Social connections and mortality from all causes and from cardiovascular disease: prospective evidence from eastern Finland. Am J Epidemiol 128 2 (1988) 370-380
9. Bello N., and Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 46 (2004) 287-295
10. American Heart Association. Heart and stroke statistical update (1999), American Heart Association, Dallas (TX)
11. American Heart Association. Heart disease and stroke statistics-2006 update. Available at: http://www.americanheart.org/downloadable/heart/1105390918119HDSStats200 5Update.pdf. Accessed December 1, 2008.
12. Sowers. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158 (1998) 617-621
13. Vaccarino V., Parsons L., Every N.R., et al. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 341 (1999) 217-225
14. Lerman G., and Sopko G. Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) study: are we smarter?. J Am Coll Cardiol 47 Suppl 3 (2006) S59-S62
15. Mosca L., Manson J.E., Sutherland S.E., et al. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 96 (1997) 2468-2482
16. Jani S.M., Montoye C., Mehta R., et al. Sex differences in the application of evidence-based therapies for the treatment of acute myocardial infarction. Arch Intern Med 166 (2006) 1164-1170
17. Greenland P., and Gulati M. Improving outcomes for women with myocardial infarction. Arch Intern Med 166 (2006) 1162-1163
18. American Heart Association Scientific Statement. Percutaneous coronary intervention and adjunctive pharmacotherapy in women. Circulation: journal of the American Heart Association 111 (2005) 940-953
19. Keyhani, Scobie J.V., Hebert P.L., et al. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 51 (2008) 1149-1155
20. Witt B.J., Jacobsen S.J., Weston S.A., et al. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 44 (2004) 988-996
21. Daly C., Clemens F., and Lopez Sendon J.L. Cardiovascular disease in women: gender differences in the management and clinical outcome of stable angina. Circulation 113 (2006) 490-498
22. Weisz D., Gusmano M.K., and Rodwin V.G. Gender and the treatment of heart disease in older persons in the United States, France, and England: a comparative, population-based view of a clinical phenomenon. Gend Med 1 (2004) 29-40
23. Healy B. The Yentl syndrome. N Engl J Med 325 (1991) 274-276
24. Milner KA, Funk M, Richards S, et al. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol; 84(4);396-9.
25. Mosca L., Appel L.J., Benjamin E.J., et al. Evidence based guidelines for cardiovascular disease prevention in women. Circulation 109 (2004) 672-693
26. Daviglus M.L., Stamler J., Pirzada A., et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 292 (2004) 1588-1592
27. The Harvard Medical School Family Health Guide. A better way to predict cardiovascular risk. Available at: http://www.health.harvard.edu/fhg/updates/a-better-way-to-predict-cardio vascular-risk.shtml. Accessed December 2, 2008.
28. May M., Lawlor D.A., Brindle P., et al. Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health Prospective Cohort Study. Heart 92 (2006) 1396-1401
29. Stampfer M.J., Hu F.B., Mansonx J.E., et al. Primary prevention of coronary heart disease in women through diet and exercise. N Engl J Med 343 (2000) 16-22
30. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 9438 (2004) 937-952
31. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290 (2003) 891-897
32. U.S. Department of Health and Human Services. Healthy people 2000: national health promotion and disease prevention objectives. DHHS Pub. No. (PHS) 91-50212 (1991), U.S. Government Printing Office, Washington, DC Sclar ED. Community economic structure and individual well-being: a look behind the statistics. International Journal of Health Services 1980;10:563-79
33. Haskell W.L., Lee I.M., Pate R.R., et al. Physical activity and public health-updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116 (2007) 1081-1093
34. American Heart Association. 1998 heart and stroke statistical update (1997), American Heart Association, Dallas (TX)
35. Anastos K., Charney P., and Charon R.A. Hypertension in women: what is really known? The Woman's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 115 (1991) 287-293
36. Keyhani S., Scobie J.V., Hebert P.L., et al. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension 51 (2008) 1149-1155
37. Mohiuddin S.M., Mooss A.N., Hunter C.B., et al. Intensive smoking cessation intervention reduced mortality in high risk smokers with cardiovascular disease. Chest 131 (2007) 446-452
38. Al-Delaimy W.K., Manson J.E., Solomon C.G., et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 162 (2002) 273-279
39. Bowman T.S., Gaziano J.M., Buring J.E., et al. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 50 (2007) 2085-2092
40. Centers for Disease Control and Prevention. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General (2006), U.S. Department of Health and Human Services, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA)
41. Whincup P.H., Gilg J.A., Emberson J.R., et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ 329 7459 (2004) 200-205
42. Fielding J.E. Smoking and women. Tragedy of the majority. N Engl J Med 317 (1987) 1343-1345
43. Tobacco use: United States, 1900-1999, from morbidity and mortality weekly report. Available at: http://www.cancernetwork.com/display/article/10165/81348. Accessed December 3, 2008.
44. Willett W.C., Green A., Stampfer M.J., et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317 (1987) 1303-1309
45. Centers for Disease Control and Prevention. Women and smoking: a report of the Surgeon General (2001), U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA)
46. Centers for Disease Control and Prevention. The health consequences of smoking: a report of the Surgeon General (2004), Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA)
47. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. Available at: http://www.bmj.com/cgi/reprint/328/7455/1519. Accessed December 3, 2008.
48. Taylor Jr. D.H., Hasselblad V., Henley S.J., et al. Benefits of smoking cessation for longevity. Am J Public Health 92 6 (2002) 990-996
49. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273 (1995) 402-407
50. Pazoki P., Nabipour I., Seyednezami N., et al. Effects of a community-based healthy heart program on increasing women's physical activity: a controlled trial guided by community-based participatory research (CBPR). BMC Public Health 7 (2007) 216
51. Gaillard. Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women. Nurse Res Prev Cardiol (2007)
52. Lerner D.J., and Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26 year follow-up of the Framingham population. Am Heart J 111 (1986) 383-390
53. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
54. Zhang C., Rexrode K.M., van Dam R.M., et al. Abdominal obesity and risk of all-cause cardiovascular, and cancer mortality. Circulation 117 (2008) 1658-1667
55. Grundy S.M., Becker D., Clark L.T., et al. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol. Circulation 106 (2002) 3143-3421
56. Schrott H.G., Bittner V., Herrington D.M., et al. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. JAMA 277 16 (1997) 1281-1286
57. Safeer R.S., and Lacivita C.L. Choosing drug therapy for patients with hyperlipidemia. Am Fam Physician 61 11 (2000) 3371-3382
58. Bass K.M., Newschaffer C.J., Klag M.J., et al. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 153 19 (1993) 2209-2216
59. Baron A.A., and Baron S.B. High levels of HDL cholesterol do not predict cardiovascular disease in women. Prev Cardiol 10 3 (2007) 125-127
60. Moat. Plasma total homocysteine: instigator or indicator of cardiovascular disease?. Ann Clin Biochem 45 (2008) 345-348
61. Ward M., McNulty H., McPartlin J., et al. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM 90 (1997) 519-524
62. Bazzano L.A., Reynolds K., Holder K.N., et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296 (2006) 2720-2726
63. Wijendran V., and Hayes K.C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr 24 (2004) 597-615
64. Bandyopadhyay S., Bayer A., and O Mahony M. Age and gender bias in statin trials. QJM 94 (2001) 127-132
65. Harris D.J., and Douglas P.S. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 343 (2000) 475-480
66. Mizuno K, Nakaya N, Ohashi Y, et al. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA Study). Circulation 117:494-502.
67. LaRosa. Effects of statins on risk of coronary disease: a meta analysis of randomized trials. JAMA 282 (1999) 2340-2346
68. Lewis S.J., Sacks F.M., Mitchell J.S., et al. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol 32 (1998) 140-146
69. Heart Protection Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
70. Walsh J.M., and Pignone M. Drug treatment of hyperlipidemia in women. JAMA 219 (2004) 2243-2252
71. Strom B.L. Statins and over-the-counter availability. N Engl J Med 352 (2005) 1403-1405
72. Pasternak R.C., Smith Jr. S.C., Bairey-Merz C.N., et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 40 (2002) 567-572
73. Whelan A.M., Price S.O., Fowler S.F., et al. The effect of aspirin on niacin-induced cutaneous reactions. J Fam Pract 34 (1992) 165-168
74. Frick M.H., Elo O., Haapa K., et al. Helsinki heart study primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317 (1987) 1237-1245
75. Meagher E.A. Addressing cardiovascular disease in women: focus on dyslipidemia. The Journal of the American Board of Family Practice 17 (2004) 424-437
76. Gardiner P., Graham R.E., Legedza A.T., et al. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 166 (2006) 1968-1974
77. U.S. Food and Drug Administration. Avoid red yeast rice promoted for high cholesterol. Available at: http://www.fda.gov/consumer/updates/redyeastrice081007.html. Accessed December 4, 2008.
78. Gardner C.D., Lawson L.D., Block E., et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 167 4 (2007) 346-353
79. American Diabetes Association. Available at:http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Accessed December 5, 2008.
80. Barrett-Conner E., Cohn B., WingardSeyednezami D.N., et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?. JAMA 265 (1991) 627-631
81. American Diabetes Association. Available at: http://www.diabetes.org/diabetes-statistics/heart-disease.jsp. Accessed December 4, 2008.
82. Selvin E., Marinopoulos S., Berkenblit G., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 (2004) 421-431
83. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24):2560-2572.
84. Gerstein H.C., and Miller M.E. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 24 (2008) 2545-2559
85. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008;31(Suppl 1):S12-54.
86. Mohandas B., Mehta J.L., et al. Lessons from the hormone replacement therapy trials for primary prevention of cardiovascular disease. Curr Opin Cardiol 22 (2007) 434-442
87. Mozaffarian D., Kumanyika S.K., Lemaitre R.N., et al. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA 289 (2003) 1659-1666
88. Hayden M., Pignone M., Phillips C., et al. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 136 (2002) 161-172
89. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352(13):1293-1304.
90. Pignone M., Earnshaw S., Pletcher M.J., et al. Aspirin for primary prevention of cardiovascular disease in women. Arch Intern Med 167 3 (2007) 290-295
91. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
92. Lawlor D.A., Bedford C., Taylor M., et al. Aspirin use for the prevention of cardiovascular disease: the British Women's Heart and Health Study. Br J Gen Pract 51 470 (2001) 743-745
93. Bhatt D.L., Fox K.A., Werner Hacke C.B., et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. NEJM 354 16 (2006) 1706-1717
94. Walsh B.W., Schiff I., Rosner B., et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325 17 (1991) 1196-1204
95. Petitti D.B., Sidney S., Quesenberry C.P., et al. Hormone replacement therapy and heart disease prevention: experimentation trumps observation. JAMA 280 7 (1998) 650-652
96. Gibbons R.F. Electrocardiography testing with and without radionuclide studies. In: Wenger N.K., Speroff L., and Packard B. (Eds). Cardiovascular health and disease in women 73 (1993), Lejaq Comms, Greenwich (CT)
97. Travin M.I., and Johnson L.L. Assessment of coronary artery disease in women. Curr Opin Cardiol 12 (1997) 587-594
98. Mieres J.H., Shaw L.J., Arai A., et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation 111 (2005) 682-696
99. Alexander K.P., Shaw L.J., DeLong E.R., et al. Value of exercise treadmill testing in women. J Am Coll Card 32 (1998) 1657-1664
100. DeCara J.M. Noninvasive cardiac testing in women. J Am Med Womens Assoc 58 4 (2003) 254-263
101. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update. American Heart Association. Available at: http://circ.ahajournals.org/cgi/content/full/117/4/e25. Accessed December 4, 2008.
102. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression, dilution bias. Lancet 335 (1990) 765-774
103. Hu F.B., and Stampfer M.J. Physical activity-nurses health study. JAMA 283 (2000) 2961-2967
104. Johnston S.C., and Gress D.R. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284 22 (2000) 2901-2906